Delivery Order SPE2DB22D2006-SPE2DB25FW2ZB
- Not listed
- The Defense Logistics Agency (DLA) awarded a $3,668.62 delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,692.06 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This competitive contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count) with a ceiling value of $3,968.44. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is classified as a delivery order, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 12, 2025, with a contract ceiling value of $3,769.60 and an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and represents a pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,640.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Progesterone 200 mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will perform this delivery from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract valued at $32,928.71. The award, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on August 12, 2025, with a contract ceiling value of $1,669.70. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 13, 2025. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,109.36. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract contains no set-aside designation, and performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,037.39 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price, competitively awarded contract was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 100 mg capsules (100-count units) valued at $1,083.44. This competitively awarded, firm fixed-price delivery order was established on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2ZBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $6,082.96, with an ultimate completion date of July 31, 2025. This non-set-aside delivery order was competitively awarded and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare supplier, fulfills this delivery order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare systems. AmerisourceBergen's DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver a broad range of medications, vaccines, medical devices, and healthcare commodities to support Defense Health Agency operations and other government healthcare customers worldwide. The company's demonstrated capability to fulfill such requirements through competitive procurement, combined with its extensive federal contract portfolio, positions it as a key vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/30/25 |